NewslettersHematopoiesis NewsMesenchymal Cell NewsUmbilical & Placental Cell News Emmes Announces Its Work on a Phase III Clinical Trial for Breakthrough Therapy Designation Product By Justin.choi - June 18, 2020 0 Emmes announced that it provided the Phase III clinical trial support for a new investigational cell therapy that offers a promising treatment opportunity for patients who need an allogeneic bone marrow transplant. [Emmes (PR Newswire, Inc.)] Press Release